The purpose of this study is to investigate the efficacy and safety of efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy.
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
For Researchers
Questions?